This inventor holds 1 USPTO granted patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovator Yuhai Xing: Pioneering Advances in IRAK4 Inhibition
Introduction: Yuhai Xing, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of pharmaceutical innovations. His commitment to advancing medical science is reflected in his patented work, particularly focusing on a crucial target in disease treatment.
Latest Patents: Yuhai Xing holds a patent for an IRAK4 inhibitor crystal and its preparation method. The patent outlines a crystal of a compound of a specified formula, including salts and their crystalline forms. Furthermore, it provides a method for synthesizing the crystal. This innovation is crucial for drug development aimed at treating diseases related to IRAK4, highlighting its potential to influence future therapeutic strategies.
Career Highlights: Currently, Yuhai Xing is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His work has garnered attention for its potential to enhance treatment options for various illnesses.
Collaborations: Throughout his career, Yuhai Xing has collaborated with notable coworkers, including Shuhui Chen and Jianfei Wang. Together, they contribute to ongoing research and development efforts, emphasizing teamwork in driving innovations forward.
Conclusion: Yuhai Xing's contributions through his patent and collaboration with peers signify important strides in the field of pharmaceuticals. His work lays the groundwork for future discoveries and improvements in the treatment of IRAK4-related diseases, showcasing the vital role inventors play in advancing medical science.